MBRX icon

Moleculin Biotech
MBRX

Overview Fund Activity

8 hedge funds and large institutions have $326K invested in Moleculin Biotech in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IG
1
ING Group
Netherlands
$132K
2
SIM
2
Spark Investment Management
New York
$124K
3
Citigroup
3
Citigroup
New York
$33K
4
TRCT
4
Tower Research Capital (TRC)
New York
$9K
5
Barclays
5
Barclays
United Kingdom
$9K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
IG
1
ING Group
Netherlands
$132K 20,000 +20,000 New
SIM
2
Spark Investment Management
New York
$124K 18,800 +18,800 New
Citigroup
3
Citigroup
New York
$33K 5,000 +5,000 New
Barclays
4
Barclays
United Kingdom
$9K 1,348 +1,348 New
TRCT
5
Tower Research Capital (TRC)
New York
$9K 1,349 +1,349 New
UBS Group
6
UBS Group
Switzerland
$8K 1,091 +1,091 New
Morgan Stanley
7
Morgan Stanley
New York
$8K 1,200 +1,200 New
NFG
8
Next Financial Group
Texas
$3K 500 +500 New